Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-10 of  331 results for ""Hydroxymethylglutaryl-CoA Reductase Inhibitors""

Your Filters

Language : french Format : Academic Journals
Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

[First-line treatment of hypercholesterolemia : start with statin monotherapy or ezetimibe-statin combination ?]

  • Authors : Scheen A; Service de Diabétologie, Nutrition et Maladies métaboliques, CHU Liège, Belgique.; Wallemacq C

Subjects: Anticholesteremic Agents*/Anticholesteremic Agents*/Anticholesteremic Agents*/therapeutic use ; Azetidines*/Azetidines*/Azetidines*/therapeutic use ; Hydroxymethylglutaryl-CoA Reductase Inhibitors*/Hydroxymethylglutaryl-CoA Reductase Inhibitors*/Hydroxymethylglutaryl-CoA Reductase Inhibitors*/therapeutic use

  • Source: Revue medicale de Liege [Rev Med Liege] 2024 Apr; Vol. 79 (4), pp. 202-207.Publisher: Hopital De Baviere Country of Publication: Belgium NLM ID: 0404317 Publication Model: Print Cited Medium: Print ISSN: 0370-629X

Record details

Read More Add to Saved list
×
Academic Journal

[For which patients do the latest lipid lowering treatments reduce cardiovascular events?]

  • Authors : Bardoczi JB; Institut universitaire de médecine de famille (BIHAM), Université de Berne, 3012 Berne.; Consultation des lipides, Département de médecine interne, Hôpital de l'Île, Hôpital universitaire de Berne, 3010 Berne.

Subjects: Cardiovascular Diseases*/Cardiovascular Diseases*/Cardiovascular Diseases*/etiology ; Cardiovascular Diseases*/Cardiovascular Diseases*/Cardiovascular Diseases*/prevention & control ; Hydroxymethylglutaryl-CoA Reductase Inhibitors*/Hydroxymethylglutaryl-CoA Reductase Inhibitors*/Hydroxymethylglutaryl-CoA Reductase Inhibitors*/therapeutic use

  • Source: Revue medicale suisse [Rev Med Suisse] 2024 Mar 06; Vol. 20 (864), pp. 472-479.Publisher: Médecine et Hygiène Country of Publication: Switzerland NLM ID: 101219148 Publication Model: Print Cited Medium: Print ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

[Evolocumab (Repatha®) : new therapy ofhypercholesterolaemia for secondary prevention of atherosclerotic disease].

  • Authors : Scheen A; Service de Diabétologie, Nutrition et Maladies métaboliques, CHU Liège, Belgique.; Wallemacq C

Subjects: Anticholesteremic Agents*/Anticholesteremic Agents*/Anticholesteremic Agents*/therapeutic use ; Hydroxymethylglutaryl-CoA Reductase Inhibitors*/Hydroxymethylglutaryl-CoA Reductase Inhibitors*/Hydroxymethylglutaryl-CoA Reductase Inhibitors*/therapeutic use ; Cardiovascular Diseases*/Cardiovascular Diseases*/Cardiovascular Diseases*/chemically induced

  • Source: Revue medicale de Liege [Rev Med Liege] 2023 Oct; Vol. 78 (10), pp. 593-600.Publisher: Hopital De Baviere Country of Publication: Belgium NLM ID: 0404317 Publication Model: Print Cited Medium: Print ISSN: 0370-629X

Record details

Read More Add to Saved list
×
Academic Journal

[Prescriptions of statins in the elderly according to the type of healthcare establishment: An example of the usefulness of territorial hospital groups].

  • Authors : Amsallem A; Pôle pharmaceutique, CHRU Jean-Minjoz, 3, boulevard Alexander-Fleming, 25030 Besançon cedex, France.; Berthou-Contreras J

Subjects: Hydroxymethylglutaryl-CoA Reductase Inhibitors*/Hydroxymethylglutaryl-CoA Reductase Inhibitors*/Hydroxymethylglutaryl-CoA Reductase Inhibitors*/therapeutic use ; Hydroxymethylglutaryl-CoA Reductase Inhibitors*/Hydroxymethylglutaryl-CoA Reductase Inhibitors*/Hydroxymethylglutaryl-CoA Reductase Inhibitors*/adverse effects ; Cardiovascular Diseases*/Cardiovascular Diseases*/Cardiovascular Diseases*/chemically induced

  • Source: Annales pharmaceutiques francaises [Ann Pharm Fr] 2023 Mar; Vol. 81 (2), pp. 346-353. Date of Electronic Publication: 2022 Jun 18.Publisher: Elsevier Masson Editeur Country of Publication: France NLM ID: 2985176R Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

[Inclisiran (Leqvio®), a potent cholesterol-lowering agent by inhibiting PCSK9 using small interfering RNA-based innovative therapy].

  • Authors : Scheen AJ; Service de Diabétologie, Nutrition et Maladies métaboliques, Département de Médecine interne, CHU Liège, Belgique.; Wallemacq C

Subjects: Cardiovascular Diseases* ; Anticholesteremic Agents*/Anticholesteremic Agents*/Anticholesteremic Agents*/pharmacology ; Anticholesteremic Agents*/Anticholesteremic Agents*/Anticholesteremic Agents*/therapeutic use

  • Source: Revue medicale de Liege [Rev Med Liege] 2022 Dec; Vol. 77 (12), pp. 745-751.Publisher: Hopital De Baviere Country of Publication: Belgium NLM ID: 0404317 Publication Model: Print Cited Medium: Print ISSN: 0370-629X

Record details

Read More Add to Saved list
×
Academic Journal

[A practitioner's perspective of the latest lipid guidelines].

  • Authors : Ponet L; Service de médecine de premier recours, Département de médecine de premiers recours, Hôpitaux universitaires de Genève, 1211 Genève 14.; Franchetti L

Subjects: Anticholesteremic Agents*/Anticholesteremic Agents*/Anticholesteremic Agents*/therapeutic use ; Cardiovascular Diseases*/Cardiovascular Diseases*/Cardiovascular Diseases*/drug therapy ; Cardiovascular Diseases*/Cardiovascular Diseases*/Cardiovascular Diseases*/prevention & control

  • Source: Revue medicale suisse [Rev Med Suisse] 2022 Sep 28; Vol. 18 (797), pp. 1802-1805.Publisher: Médecine et Hygiène Country of Publication: Switzerland NLM ID: 101219148 Publication Model: Print Cited Medium: Print ISSN:

Record details

Read More Add to Saved list
×
Editorial & Opinion

[Prevalence of statins prescriptions among the elderly in nursing homes in West Occitania].

  • Authors : Zacarin A; Service de pharmacologie médicale et clinique, faculté de médecine, centre de pharmacovigilance, de pharmacoepidémiologie et d'informations sur le médicament, CHU, université Paul-Sabatier, 31000 Toulouse, France.; Zogheib ML

Subjects: Hydroxymethylglutaryl-CoA Reductase Inhibitors*/Hydroxymethylglutaryl-CoA Reductase Inhibitors*/Hydroxymethylglutaryl-CoA Reductase Inhibitors*/therapeutic use; Aged ; Humans

  • Source: Therapie [Therapie] 2022 May-Jun; Vol. 77 (3), pp. 384-386. Date of Electronic Publication: 2021 Jun 09.Publisher: Elsevier Masson Country of Publication: France NLM ID: 0420544 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

[Rhabdomyolysis with tetraparesis secondary to hepatitis E virus infection in a patient on statins].

  • Authors : Hanotte B; Service de médecine interne, hôpital Nord, CHU de Saint-Étienne, 42055 Saint-Étienne cedex 02, France.; Gaultier JB

Subjects: Hepatitis E*/Hepatitis E*/Hepatitis E*/complications ; Hepatitis E*/Hepatitis E*/Hepatitis E*/diagnosis ; Hepatitis E virus*

  • Source: La Revue de medecine interne [Rev Med Interne] 2022 Apr; Vol. 43 (4), pp. 252-255. Date of Electronic Publication: 2022 Feb 04.Publisher: Elsevier Country of Publication: France NLM ID: 8101383 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1768-3122

Record details

Read More Add to Saved list
×
Academic Journal

[High-dose Omega-3 for cardiovascular prevention, a bad idea?]

  • Authors : Berger C; Policlinique de médecine générale, Unisanté, 1011 Lausanne.; Gencer B

Subjects: Cardiovascular Diseases*/Cardiovascular Diseases*/Cardiovascular Diseases*/etiology ; Cardiovascular Diseases*/Cardiovascular Diseases*/Cardiovascular Diseases*/prevention & control ; Fatty Acids, Omega-3*/Fatty Acids, Omega-3*/Fatty Acids, Omega-3*/therapeutic use

  • Source: Revue medicale suisse [Rev Med Suisse] 2022 Mar 09; Vol. 18 (772), pp. 434-437.Publisher: Médecine et Hygiène Country of Publication: Switzerland NLM ID: 101219148 Publication Model: Print Cited Medium: Print ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

[Bempedoïc acid, new cholesterol-lowering drug].

  • Authors : Scheen AJ; Service de Diabétologie, Nutrition et Maladies métaboliques , CHU Liège, Belgique.; Paquot N

Subjects: Anticholesteremic Agents*/Anticholesteremic Agents*/Anticholesteremic Agents*/adverse effects ; Hydroxymethylglutaryl-CoA Reductase Inhibitors*/Hydroxymethylglutaryl-CoA Reductase Inhibitors*/Hydroxymethylglutaryl-CoA Reductase Inhibitors*/adverse effects ; Pharmaceutical Preparations*

  • Source: Revue medicale de Liege [Rev Med Liege] 2022 Feb; Vol. 77 (2), pp. 124-131.Publisher: Hopital De Baviere Country of Publication: Belgium NLM ID: 0404317 Publication Model: Print Cited Medium: Print ISSN: 0370-629X

Record details

Read More Add to Saved list
×
  • 1-10 of  331 results for ""Hydroxymethylglutaryl-CoA Reductase Inhibitors""